Can clinical parameters of patients, sans serum prolactin measurement, identify amenorrhea associated with risperidone use? Results from a cross-sectional analytical study
Background: Risperidone is a second-generation antipsychotic, which exerts its action by antagonizing dopamine (D2) and serotonin (5-HT2A) receptors. Amenorrhea is a common adverse effect observed in risperidone. Risperidone blocks the dopamine receptor of lactotroph cells of the pituitary gland, re...
Main Authors: | Vigneshvar Chandrasekaran, Avin Muthuramalingam, Karthick Subramanian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Current Research in Scientific Medicine |
Subjects: | |
Online Access: | http://www.jcrsmed.org/article.asp?issn=2455-3069;year=2022;volume=8;issue=2;spage=135;epage=139;aulast=Chandrasekaran |
Similar Items
-
Switching to quetiapine for risperidone-induced amenorrhea: Report of two cases
by: P K Pardal, et al.
Published: (2010-01-01) -
Risperidone induced amenorrhea and galactorrhea in a case of an adolescent patient
by: Bradley Brown, et al.
Published: (2017-01-01) -
Effect of risperidone on the cravings of patients with methamphetamine use disorder
by: N. Hassan, et al.
Published: (2022-06-01) -
Risperidone induced angioedema with concurrent EPS symptoms: a case report and review of literature
by: Gursharan Singh Samra, et al.
Published: (2018-03-01) -
Advanced Drug Delivery Technologies for Enhancing Bioavailability and Efficacy of Risperidone
by: Rathi R, et al.
Published: (2024-11-01)